ARANA THERAPEUTICS LIMITED (AAH)

Previously known as: PEPTECH LIMITED (PTD)

ASX code: AAH
Listing Date: Thu, 23 Jan 1986
Website: http://www.arana.com
Industry: Pharmaceuticals, Biotechnology & Life Sciences

Principal Activities:
An international biopharmaceutical company formed through the merger of Peptech and EvoGenix in August 2007. The company uses superior technology to develop next generation drugs that will improve the lives of patients with inflammatory diseases and cancer.

Address:
37 Epping Road, Level 2
MACQUARIE PARK
NSW 2113

Phone: (02) 8061 9900
Fax: (02) 8061 9999

Executives & Directors

Mr Robin Beaumont, Chairman
Dr John Chiplin, Managing Director, CEO
Dr George Jessup, Director
Dr Lincoln Chee, Non Exec. Director
Mr Chris Harris, Independent Director, Non Exec. Director
Mr Niall Henderson, CFO

Please contact the ASX to change these details

Company Podcasts

Subscribe to current and future audio events for this company by clicking on the podcast icon:

Company ASX Announcements

Company ASX announcements can be viewed on the ASX website.
Announcements from the preceding six months are shown below.

View this company's details on the Australian Securities Exchange website

ARANA THERAPEUTICS LIMITED (AAH) Events

Company (Stock Code)	Date/Time	Event
ARANA THERAPEUTICS LIMITED (AAH) ART621 Reaches Key Milestone	Thu, 28 Aug 2008 04:30PM	AAH - Arana Announces Key Anti-Inflammatory Drug Milestone - Dr David Fuller, Chief Medical Officer
ARANA THERAPEUTICS LIMITED (AAH)	Wed, 6 Aug 2008 03:45PM	AAH - 6th Annual Australian Biotechnology Summit 2008, Corporate Overview - Dr John Chiplin, CEO
ARANA THERAPEUTICS LIMITED (AAH)	Thu, 3 Jul 2008 12:15PM	AAH - Grand Opening Macquarie Park Facility - Senator The Hon Kim Carr, Minister for Innovation, Industry, Science and Research
ARANA THERAPEUTICS LIMITED (AAH)	Thu, 3 Jul 2008 12:00PM	AAH - Grand Opening Macquarie Park Facility - Dr John Chiplin, CEO
ARANA THERAPEUTICS LIMITED (AAH)	Tue, 24 Jun 2008 04:00PM	AAH - Discussion on the 2008 BIO International Convention in San Diego - Dr Steffen Nock, President Arana Therapeutics Inc
ARANA THERAPEUTICS LIMITED (AAH)	Thu, 22 May 2008 03:30PM	AAH - Arana Reports Strong Financial Position - Dr John Chiplin Managing Director, CEO and Mr Niall Henderson CFO
ARANA THERAPEUTICS LIMITED (AAH)	Mon, 28 Apr 2008 03:35PM	AAH - Arana and Kyowa Hakko to Co-Develop Anti-Cancer Drug - Dr Cliff Holloway, Vice President of Business Development
ARANA THERAPEUTICS LIMITED (AAH)	Wed, 23 Apr 2008 12:15PM	Excellence in Biotechnology Investment - Mr John Chiplin, CEO, Arana Therapeutics
ARANA THERAPEUTICS LIMITED (AAH)	Tue, 18 Mar 2008 03:00PM	AAH - Commencement of Phase II Trials for Lead Compound ART621 - Dr John Chiplin, CEO and Managing Director and Dr David Fuller, Chief Medical Officer
ARANA THERAPEUTICS LIMITED (AAH)	Tue, 18 Mar 2008 12:00PM	AAH - Sky TV Update on Phase II Trial Status - Dr John Chiplin, CEO
ARANA THERAPEUTICS LIMITED (AAH)	Wed, 5 Dec 2007 12:00PM	AAH - Announes Phase II Trials for Lead Compound ART621 - Dr David Fuller, Chief Medical Officer
ARANA THERAPEUTICS LIMITED (AAH)	Fri, 30 Nov 2007 12:40PM	AAH - Arana Therapeutics Completes Project With CSL - Dr Rob Crombie, VP Business Development
ARANA THERAPEUTICS LIMITED (AAH)	Thu, 8 Nov 2007 12:30PM	AAH - New Direction, New Name, New Future - Dr John Chiplin, CEO
ARANA THERAPEUTICS LIMITED (AAH)	Thu, 9 Aug 2007 03:00PM	[PTD] PTD - Shareholders Approve Peptech-Evogenix Merger - Dr John Chiplin, CEO
ARANA THERAPEUTICS LIMITED (AAH)	Thu, 12 Jul 2007 12:30PM	[PTD] PTD - Peptech presentation to eG Capital Forum - Dr John Chiplin, CEO
ARANA THERAPEUTICS LIMITED (AAH)	Wed, 6 Jun 2007 11:30AM	[PTD] PTD - Merger Roadshow Presentation - Dr John Chiplin, MD; Dr Phil Jennings, Exec. Director and Dr Cliff Holloway, VP of Bus. Development
ARANA THERAPEUTICS LIMITED (AAH)	Tue, 22 May 2007 02:00PM	[PTD] PTD - Enters Phase I Clinical Trials - Dr Phil Jennings, Executive Director
ARANA THERAPEUTICS LIMITED (AAH)	Thu, 17 May 2007 04:30PM	[PTD] PTD - Record Profit for Half Year - Dr John Chiplin, MD
ARANA THERAPEUTICS LIMITED (AAH)	Mon, 7 May 2007 11:00AM	[PTD] PTD - Peptech & EvoGenix Merge to Form Antibody Powerhouse - Dr John Chiplin and Dr Merilyn Sleigh
ARANA THERAPEUTICS LIMITED (AAH)	Wed, 14 Mar 2007 05:00PM	[PTD] PTD - Appoints Global Financial Adviser to Examine Strategic Options - Dr John Chiplin, CEO
ARANA THERAPEUTICS LIMITED (AAH)	Wed, 21 May 2008	Interim Results
ARANA THERAPEUTICS LIMITED (AAH)	Thu, 14 Feb 2008 03:00PM	Annual General Meeting The Wesley Conference Centre, 220 Pitt Street, Sydney, NSW, 2000
ARANA THERAPEUTICS LIMITED (AAH)	Fri, 11 Jan 2008	Full Year Results
ARANA THERAPEUTICS LIMITED (AAH)	Fri, 9 Nov 2007	[PTD] Full Year Results
ARANA THERAPEUTICS LIMITED (AAH)	Thu, 17 May 2007	[PTD] Interim Results
ARANA THERAPEUTICS LIMITED (AAH)	Mon, 8 Jan 2007 10:00AM	[PTD] Annual General Meeting 220 Pitt Street Sydney NSW
ARANA THERAPEUTICS LIMITED (AAH)	Fri, 3 Nov 2006	[PTD] Full Year Results
ARANA THERAPEUTICS LIMITED (AAH)	Thu, 18 May 2006	[PTD] Interim Results
ARANA THERAPEUTICS LIMITED (AAH)	Wed, 15 Feb 2006 10:00AM	[PTD] Annual General Meeting 4th Floor, 20 Bridge Street Sydney NSW 2000
ARANA THERAPEUTICS LIMITED (AAH)	Tue, 15 Feb 2005 10:00AM	[PTD] Annual General Meeting The Wesley Conference Centre, 220 Pitt Street, Sydney, NSW
Displaying 1-20 of 33 events		Display

ARANA THERAPEUTICS LIMITED (AAH)

Click here to view details on the ASX site

Arana Announces Key Anti-Inflammatory Drug Milestone	Thu, 28 Aug 2008
Arana news - August 2008	Mon, 18 Aug 2008
Results of Meeting	Wed, 13 Aug 2008
Arana Therapeutics Expands Clinical Research Team	Mon, 28 Jul 2008
Notice of General Meeting/Proxy Form	Mon, 14 Jul 2008
Change in substantial holding	Wed, 25 Jun 2008
Half year shareholder report	Wed, 25 Jun 2008
Arana Therapeutics completes second project with CSL	Thu, 5 Jun 2008
Arana and Greenovation enter into a collaboration agreement	Tue, 3 Jun 2008
Change of Director`s Interest Notice	Fri, 23 May 2008

Please note: This company appears on this website as a result of its listing on the Australian Securities Exchange. Boardroom Radio does not claim any association with any company listed on this site.